Sofosbuvir for treating chronic hepatitis C
 
Status Complete
Process STA
Referral date October 2013
Topic area
  • Digestive system
  • Infectious diseases
Description

Scoped as part of Batch 31

Timeline

Key events during the development of the guidance:

Date Update
8 December 2014 Following the Technology Appraisal Committee meeting on 14 October 2014, we are consulting with consultees and commentators on the case for extending the statutory 3-month period for deferred funding of sofosbuvir for the treatment of chronic hepatitis C. Once this consultation has ended, we will issue the Final Appraisal Determination (FAD) for appeal and anticipate publishing guidance on this appraisal in January 2015.
September 2014 Following the meeting on 10 September, the committee have requested that further analyses be provided by the company. The additional analyses will be discussed at a further committee meeting on 14 October 2014.
30 July 2014 Following the committee meeting discussion on 15 July 2014, the committee have asked NICE to prepare a further Appraisal Consultation Document (ACD). Following consultation, this will be discussed again at a further committee meeting.

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance